MYC and neoplasm: Subsequently, somatic mutations in common tumor-related pathways in both subtypes were evaluated, including the RTK-RAS, NOTCH, WNT, Hippo, PI3K, TP53, TGF-Beta, NRF2, MYC, and Cell Cycle pathways.